Temporal trends in mortality rates from visceral vein thrombosis in paroxysmal nocturnal haemoglobinuria: An optimistic view

Loukia S. Poulou; Vassilia Xila; George I. Rokas; George Karianakis; Dimitrios Bartzoudis; Panayiotis D. Ziakas

doi:10.1160/TH07-11-0664

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2008; 99(03): 642-645
DOI: 10.1160/TH07-11-0664

Letters to the Editor

Schattauer GmbH

Temporal trends in mortality rates from visceral vein thrombosis in paroxysmal nocturnal haemoglobinuria: An optimistic view

Loukia S. Poulou

¹Department of Radiology, “Agioi Anargyroi” Hospital, Athens, Greece

,

Vassilia Xila

²Department of Internal Medicine, “Sotiria” General Hospital for Chest Disease, Athens, Greece

,

George I. Rokas

³2nd Department of Surgery, Medical School, University of Athens, Greece

,

George Karianakis

⁴Bone Marrow Transplantation Unit, ‘Hygeia’ Hospital, Athens, Greece

,

Dimitrios Bartzoudis

⁵Hematology Department, G. Papanicolaou Hospital, Thessaloniki, Greece

,

Panayiotis D. Ziakas

⁴Bone Marrow Transplantation Unit, ‘Hygeia’ Hospital, Athens, Greece

References
1 Ziakas PD, Poulou LS, Rokas GI. et al. Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 2007; 5: 642-645.
2 Grossman JA, McDermott WV. Jr. Paroxysmal nocturnal hemoglobinuria associated with hepatic and portal venous thrombosis. Am J Surg 1974; 127: 733-736.
3 Sholar PW, Bell WR. Thrombolytic therapy for inferior vena cava thrombosis in paroxysmal nocturnal hemoglobinuria. Ann Intern Med 1985; 103: 539-541.
4 van der Schoot CE, Huizinga TW, van't Veer-Korthof ET. et al. Deficiency of glycosyl-phosphatidylinositol- linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 1990; 76: 1853-1859.
5 Ishiguchi T, Fukatsu H, Itoh S. et al. Budd-Chiari syndrome with long segmental inferior vena cava obstruction: treatment with thrombolysis, angioplasty, and intravascular stents. J Vasc Interv Radiol 1992; 3: 421-425.
6 Ganguli SC, Ramzan NN, McKusick MA. et al. Budd- Chiari syndrome in patients with hematological disease: a therapeutic challenge. Hepatology 1998; 27: 1157-1161.
7 Brodsky RA, Mukhina GL, Li S. et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000; 114: 459-466.
8 Khuroo MS, Al-Suhabani H, Al-Sebayel M. et al. Budd-Chiari syndrome: long-term effect on outcome with transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol 2005; 20: 1494-1502.
9 Fanelli F, Salvatori FM, Corona M. et al. Stent graft in TIPS: technical and procedural aspects. Radiol Med (Torino) 2006; 111: 709-723.
10 McMullin MF, Hillmen P, Jackson J. et al. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria. J Intern Med 1994; 235: 85-89.
11 McKee CM, Mayne EE, Crothers JG. et al. Budd- Chiari syndrome treated with acylated streptokinaseplasminogen complex. J R Soc Med 1985; 78: 768-769.
12 Raju GS, Felver M, Olin JW. et al. Thrombolysis for acute Budd-Chiari syndrome: case report and literature review. Am J Gastroenterol 1996; 91: 1262-1263.
13 Bogin V, Marcos A, Shaw-Stiffel T. Budd-Chiari syndrome: in evolution. Eur J Gastroenterol Hepatol 2005; 17: 33-35.
14 Klein AS, Cameron JL. Diagnosis and management of the Budd-Chiari syndrome. Am J Surg 1990; 160: 128-133.
15 Kugelmas M. Budd-Chiari syndrome. Treatment options and the value of liver transplantation. Hepatogastroenterology 1998; 45: 1381-1386.
16 Klein AS. Management of Budd-Chiari syndrome. Liver Transpl 2006; 12: S23-28.
17 Fisher NC, McCafferty I, Dolapci M. et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999; 44: 568-574.
18 Wang ZG, Zhang FJ, Yi MQ. et al. Evolution of management for Budd-Chiari syndrome: a team’s view from 2564 patients. ANZ J Surg 2005; 75: 55-63.
19 Senzolo M, Cholongitas EC, Patch D. et al. Update on the classification, assessment of prognosis and therapy of Budd-Chiari syndrome. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 182-190.
20 Plessier A, Sibert A, Consigny Y. et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44: 1308-1316.
21 Murad SD, Valla DC, De Groen PC. et al. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006; 101: 83-90.
22 Rhee RY, Gloviczki P, Mendonca CT. et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994; 20: 688-697.
23 Brunaud L, Antunes L, Collinet-Adler S. et al. Acute mesenteric venous thrombosis: case for nonoperative management. J Vasc Surg 2001; 34: 673-679.
24 Morasch MD, Ebaugh JL, Chiou AC. et al. Mesenteric venous thrombosis: a changing clinical entity. J Vasc Surg 2001; 34: 680-684.
25 Zhang J, Duan ZQ, Song QB. et al. Acute mesenteric venous thrombosis: a better outcome achieved through improved imaging techniques and a changed policy of clinical management. Eur J Vasc Endovasc Surg 2004; 28: 329-334.
26 Grisham A, Lohr J, Guenther JM. et al. Deciphering mesenteric venous thrombosis: imaging and treatment. Vasc Endovascular Surg 2005; 39: 473-479.
27 Poulou LS, Vakrinos G, Pomoni A. et al. Stroke in paroxysmal nocturnal haemoglobinuria: patterns of disease and outcome. Thromb Haemost 2007; 98: 699-701.